MedTrace Logo

Expanding the Therapeutic Window of Deep Brain Stimulation in Parkinson's Disease by Means of Directional Leads

NCT04093544 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-18

No results posted yet for this study

Summary

Exploring directional lead

Conditions

  • Parkinson Disease

Interventions

DEVICE

Deep brain stimulation

Steered stimulation using directional leads

Sponsors & Collaborators

  • University of Toronto

    lead OTHER

Principal Investigators

  • Alfonso Fasano, MD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2020-05-15
Completion
2020-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04093544 on ClinicalTrials.gov